Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …

The liposome, a closed phospholipid bilayered vesicular system, has received considerable
attention as a pharmaceutical carrier of great potential over the past 30 years. The ability of …

It is a challenge to design photosensitizers to balance between the tumor‐targeting
enrichment for precise treatment and efficient clearance within a reasonable timescale for …

Advanced drug delivery systems using poly (ethylene glycol)(PEG) is an important
development in anti-cancer therapy. PEGylation has the ability to enhance the retention time …

The rapid advancement of nanotechnology has raised the possibility of using engineered
nanoparticles that interact within biological environments for treatment of diseases …

Despite the clinical introduction of an increasing number of polyethylene glycol (PEG)-
conjugated substances, PEG has been named as the cause of an unexpected immunogenic …

In recent years, nanotechnology has been increasingly applied to the area of drug
development. Nanoparticle-based therapeutics can confer the ability to overcome biological …

Simple Summary The current main technological strategies for the delivery of anticancer
drugs are discussed herein. This comprehensive review may help researchers design …

Lipid nanoparticles (LNP) can provide a clinically effective method for delivering small
interfering RNA (siRNA) to silence pathological genes in hepatocytes. The gene silencing …

Nanotechnology has been actively employed in the development of drug-delivery systems
overcoming the limitations of conventional carriers. In nanomedicine, the ultimate goal is to …